AnaptysBio, Inc. (ANAB) — Stock Score Summary

AnaptysBio, Inc. (ANAB) has a MoatMap StockRank of 53/100 based on Quality (47/100), Value (16/100), and Momentum (76/100) factor scores. The current signal is HOLD. AnaptysBio is a clinical-stage biotechnology company. It does not meet our Terry Smith criteria of being a quality compounder with high ROIC and predictable free cash flows.

AnaptysBio, Inc. is a clinical-stage biotechnology company focused on discovering and developing therapeutic antibodies for inflammatory and immuno-oncology diseases. Its competitive moat stems from its proprietary SHM-P antibody discovery platform, which enables rapid generation of highly potent and selective therapeutic candidates. The company is a specialized player in biopharmaceutical innovation, aiming to address significant unmet medical needs.

Key Financial Metrics

Price$51.63
Market Cap$1.7B
P/E (Forward)8.86
Price/Book117.70
Return on Equity-114.6%
Return on Invested Capital20.5%
Debt/Equity2175.84
Gross Margin44.6%
Operating Margin-135.5%
Revenue Growth-8.0%
Free Cash Flow$8M

AnaptysBio, Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is AnaptysBio, Inc.’s (ANAB) StockRank?
MoatMap’s StockRank for AnaptysBio, Inc. (ANAB) is 53/100, with a Hold signal. It is a composite of Quality (47), Value (16), and Momentum (76) factor ranks across MoatMap’s 19,000+ stock universe.
Does AnaptysBio, Inc. have an economic moat?
AnaptysBio, Inc. (ANAB) has a Quality factor score of 47/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is AnaptysBio, Inc. a buy, hold, or sell?
MoatMap’s current signal for AnaptysBio, Inc. (ANAB) is Hold, based on a StockRank of 53/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is AnaptysBio, Inc. in?
AnaptysBio, Inc. (ANAB) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksANAB deep dive reportAI ChampionsHow we score stocksSense-check another stock